Amelioration of muscle wasting by glucagon_like peptide_1 receptor agonist in muscle atrophy
Envoyer une demande de publication
close

Demande de publication

Merci pour votre intérêt pour nos produits et votre demande concernant cette publication, qui vous sera envoyée si le chercheur et le journal l'autorisent. Notre équipe commerciale vous contactera rapidement.



- Catégories : Atrophie musculaire , Publications , Système musculaire - ID: 1128

Authors
Y Hong, JH Lee, KW Jeong, CS Choi, HS Jun


Lab
College of Pharmacy, Gachon University, 7 45 Songdo-dong, Yeonsu-ku, Incheon, 406 840 , Korea

Journal
Journal of Cachexia, Sarcopenia and Muscle

Abstract
Skeletal muscle atrophy is deÞned as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon-like peptide-1 receptor (GLP1R) agonists, such as exendin-4 (Ex-4) and dulaglutide, are widely used for the treatment of diabetes, their effects on muscle pathology are unknown. In this study, we investigated the therapeutic potential of GLP-1R agonist for muscle wasting and the mechanisms involved.

BIOSEB Instruments Used:
Grip strength test (BIO-GS3)

Produits associés

Partager ce contenu